Search Results for keywords:"Public Health Emergency"

Found 6 results

Search Results: keywords:"Public Health Emergency"

💰 Only
Oldest Newest
  • 2021-04056 — Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB)
    Type:Notice
    Citation:86 FR 11780
    Reading Time:about 5 minutes

    The Centers for Medicare & Medicaid Services (CMS) is requesting emergency approval for a change to the CAHPS for MIPS survey, which will add a question about telehealth services used during the COVID-19 Public Health Emergency. This change aims to collect self-reported data from patients on their telehealth experiences to support the quality and performance assessments of healthcare providers. The new survey item will be used for informational purposes and not affect quality scoring or payments. Public comments on this proposed change are invited until April 9, 2021.

    Simple Explanation

    The Centers for Medicare & Medicaid Services (CMS) wants to ask people about how they used phone or video doctor visits during the COVID-19 pandemic. This is to understand how these visits are going, but it won't change how doctors or hospitals get their scores or money.

  • 2021-00237 — Notice That Persons That Entered the Over-the-Counter Drug Market To Supply Hand Sanitizer During the COVID-19 Public Health Emergency Are Not Subject to the Over-the-Counter Drug Monograph Facility Fee
    💰
    Type:Notice
    Citation:86 FR 2420
    Reading Time:about 5 minutes

    The Department of Health and Human Services has issued a notice clarifying that businesses that started producing hand sanitizers during the COVID-19 pandemic are not required to pay certain facility fees under the Food, Drug, and Cosmetic Act. These businesses, many of which normally produce alcoholic beverages, were allowed to make hand sanitizers due to a temporary policy by the FDA to address shortages. The Department emphasizes that imposing such fees would be inconsistent with the intent of the CARES Act and clarifies that these businesses are not considered drug manufacturing facilities under the law, unless they also engage in producing other over-the-counter drugs.

    Simple Explanation

    The government said that people who started making hand sanitizers because of the coronavirus, like some drink-makers, don't have to pay special fees usually meant for making regular medicines.

  • 2024-31194 — Agency Information Collection Activity Under OMB Review: Transit COVID-19 Response Program
    Type:Notice
    Citation:89 FR 106732
    Reading Time:about 4 minutes

    The Federal Transit Administration (FTA) is seeking public comments on their proposed information collection related to the Transit COVID-19 Response Program. This request is in compliance with the Paperwork Reduction Act of 1995 and aims to renew the existing framework for a three-year period to enable swift data collection during future public health emergencies. Although the formal COVID-19 emergency has ended, the FTA wants to continue gathering data to assess its impact on transit systems. Comments can be submitted until January 29, 2025, to the Office of Management and Budget (OMB), which will decide on the approval of this information collection.

    Simple Explanation

    The Federal Transit Administration wants to keep collecting information about how COVID-19 affected buses and trains, even though the big emergency is over, so they can be ready for any future health problems. They are asking people to share their thoughts until January 29, 2025, on whether this is a good idea or not.

  • 2021-03429 — Authorizations of Emergency Use of Certain Drug and Biological Products During the COVID-19 Pandemic; Availability
    Type:Notice
    Citation:86 FR 10290
    Reading Time:about 10 minutes

    The Food and Drug Administration (FDA) has issued five Emergency Use Authorizations (EUAs) for drugs and biological products during the COVID-19 pandemic. These authorizations, allowed under the Federal Food, Drug, and Cosmetic Act, aim to help address public health emergencies by making medical products available when there are no adequate alternatives. The products authorized include those requested by Baxter Healthcare, the U.S. Department of Health and Human Services, Eli Lilly and Company, and Regeneron Pharmaceuticals. The FDA ensures that these authorizations are based on scientific evidence indicating that the benefits of using these products outweigh the risks.

    Simple Explanation

    The FDA is letting some special medicines be used in emergencies because of COVID-19. These medicines help people when no other options are available, and were given the okay because they're believed to be more helpful than harmful.

  • 2021-03770 — Privacy Act of 1974; System of Records
    Type:Notice
    Citation:86 FR 11381
    Reading Time:about 23 minutes

    The Department of the Treasury has proposed a new system of records titled "Health Screening and Contact Tracing Records" to track individuals who have been infected with or exposed to communicable diseases while at Treasury facilities or events. This system, established under the Privacy Act of 1974, aims to protect the health of Treasury personnel and visitors by collecting necessary information for health screening and contact tracing. Treasury will use these records to comply with health and safety regulations, respond to public health emergencies, and reduce the transmission of infectious diseases. Personal information, including health data, may be shared with relevant authorities for public health purposes while maintaining privacy safeguards.

    Simple Explanation

    The people who work at a place called the Treasury want to keep everyone safe from getting sick, so they're planning to keep track of people who might have caught or been near someone with a sickness when visiting. They promise to be careful with the information they collect and only share it when they really need to, but some people are curious about how they'll protect this info and how long they'll keep it.

  • 2021-03348 — Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination During the COVID-19 Nationwide Public Health Emergency
    Type:Rule
    Citation:86 FR 11139
    Reading Time:about 10 minutes

    The Department of Health and Human Services (HHS) has announced that it will not enforce penalties on health care providers for not following certain HIPAA rules when using online scheduling applications for COVID-19 vaccinations. This leniency is because of the urgent need to schedule many vaccination appointments during the pandemic. These online tools, called Web-Based Scheduling Applications (WBSAs), are used in good faith to protect privacy, but HHS encourages implementing safety measures like encryption and data protection. This policy only applies during the COVID-19 public health emergency and is specific to scheduling vaccinations, not other medical activities.

    Simple Explanation

    The government is saying it's okay for doctors to use online tools to help people book their COVID-19 vaccine shots without following all the normal privacy rules, just to make sure everyone gets vaccinated quickly. But they still want these doctors to keep our information safe, like using secret codes to protect it.